𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pharmacokinetic and pharmacodynamic studies in man simulating acute and chronic treatment with oral pirenzepine

✍ Scribed by W. Londong; V. Londong; C. Federle; P. Tanswell; U. Voderholzer

Publisher
Springer
Year
1989
Tongue
English
Weight
1006 KB
Volume
36
Category
Article
ISSN
0031-6970

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Pharmacokinetic and pharmacodynamic stud
Pharmacokinetic and pharmacodynamic studies in man with an antianginal agent β€˜Visacor’
✍ Ian D. Cockshott; James McAinsh; Stephanie Norris πŸ“‚ Article πŸ“… 1990 πŸ› John Wiley and Sons 🌐 English βš– 531 KB

This randomized, double-blind, crossover study in 10 healthy male volunteers compared four single oral doses of ICI 141,292 ('Visacor'), i.e. 50, 100, 200, and 300 mg, with placebo. Venous blood samples were collected pre-dose and at various times after dosing and the concentrations of ICI 141,292 i

Oral pharmacokinetics of pirenzepine in
Oral pharmacokinetics of pirenzepine in patients with chronic renal insufficiency, failure, and maintenance haemodialysis
✍ T. MacGregor; K. Matzek; J. Keirns; M. Vinocur; A. Chonko πŸ“‚ Article πŸ“… 1990 πŸ› Springer 🌐 English βš– 215 KB

The pharmacokinetic properties of pirenzepine following administration of a single, 50 mg oral dose were evaluated in three groups of subjects: group I, end stage renal disease requiring maintenance haemodialysis (CLCR 0 to 10 ml.min-1); group II, moderate renal insufficiency (CLCR 10 to 30 ml.min-1